Investigators examined whether chronic pain and hypoesthesia are linked in patients with MS.
Pain in patients with multiple sclerosis may affect their daily functioning regardless of disease severity.
Percutaneous transluminal angioplasty maybe beneficial for reducing headaches in relapsing remitting and secondary progressive multiple sclerosis.
Neuropathic pain is associated with a more severe multiple sclerosis disease phenotype.
Resilience may mediate the relationships between positive affect and pain interference and depression in patients with multiple sclerosis.
Increasing evidence suggests a relationship between migraine and multiple sclerosis that is beyond comorbidity and may help clarify the pathophysiology of both disorders.
In patients with multiple sclerosis, lesions in the right dorsolateral prefrontal cortex and posterior periventricular area may be associated with hypo and hyperalgesia.
Dronabinol provides a safe and effective treatment option for patients with symptoms of neuropathic pain associated with multiple sclerosis.
Radiofrequency rhizotomy and the more expensive stereotactic radio surgery provide immediate pain relief from trigeminal neuralgia associated with multiple sclerosis.
The diagnostic criteria formulated by the ACTTION-APS Pain Taxonomy working group focus on neuropathic pain from SCI, stroke, and MS.
Patients with multiple sclerosis (MS) have lower bone mineral density and greater rates of osteoporosis than healthy controls.
A genetic variant that is associated with both multiple sclerosis and systemic lupus erythematosus has been identified.
Common Antidepressant Shows Effectiveness in Treating Multiple Sclerosis-Related Neuropathic Pain in Animal ModelJune 21, 2016
Investigating changes in structure and neuronal activity in higher sensory cortex related to pain sensitivity in an animal model of MS
Research confirms high prevalence of pain, affecting more than half of those with multiple sclerosis
The revised guidelines stress the use of high-quality imaging and consistency in images taken.
People with MS who have comorbidities may be more likely to experience disruptive pain.
Another study suggests that a telehealth system could help objectively monitor dose adherence.
Insurance coverage can be the determining factor on whether a patient receives DMT or not.
The innate lymphoid cell has demonstrated different immune activities in males when compared with females, researchers from the Northwestern Medicine lab have found.
A new antibody that inhibits MCAM activity may be the first treatment that can halt the progression of multiple sclerosis.
Clinical Pain Advisor Articles
- Perioperative Pain Management in Patients With Opioid Use Disorder
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Reviewing the Efficacy of Invasive Procedures for Chronic Back, Knee Pain
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Lower Weighting of Hand Cortical Representations in CRPS
- Predicting Success of Focal Nerve Surgery Based on Diagnostic Block Response
- Aetna-CVS Merger Approved
- FDA Announces Draft Guidance for Consumer OTC Access to Previously Prescription Drugs
- Maryland Legislature: Will Federal Courts Permit State Regulation of Drug Prices?